TF and rheumatoid arthritis: A pathway enrichment analysis of the 211 TGs targeted by more than 20% of the key TF drivers in RA highlighted the pathways “positive regulation of GTPase activity,” “Cell–substrate junction assembly,” and “negative regulation of chemotaxis,” among others (Fig 2D, Table S6).